Advertisement
Screener

Pulse Biosciences, Inc. (PLSE) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

2.3 / 5 stars · 21/45 Roast Me

Pulse Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

Pulse Biosciences, Inc. (PLSE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 65.26 thousand shares for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2021-11-15

  • Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-09-30 was 2.52K shares.
  • Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-06-30 was 0.00 shares.
  • Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2021-03-31 was 62.74K shares.
  • Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-12-31 was 92.42K shares.
  • Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2020 was 157.50K shares, a 8.17% decline from fiscal 2019.
  • Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 171.52K shares, a 2350.29% increase from fiscal 2018.
  • Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2018 was 7.00K shares, a 66.17% decline from fiscal 2017.
  • Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2017 was 20.69K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month
2021-09-302.52K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
2.52K shares
derived: sum of 2 quarters · filed 2021-11-15
65.26K shares
10-Q · filed 2021-11-15
157.68K shares
derived: sum of 4 quarters · filed 2021-11-15
2021-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
62.74K shares
10-Q · filed 2021-08-09
155.15K shares
derived: sum of 3 quarters · filed 2021-08-09
2021-03-3162.74K shares
10-Q · filed 2021-05-10
155.15K shares
derived: sum of 2 quarters · filed 2021-05-10
2020-12-3192.42K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
157.50K shares
10-K · filed 2021-03-12
2020-09-3065.09K shares
10-Q · filed 2020-11-09
2019-12-31171.52K shares
10-K · filed 2020-03-16
2018-12-317.00K shares
10-K · filed 2019-03-14
2017-12-3120.69K shares
10-K · filed 2018-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
Heartflow, Inc. (HTFL)United States$4.225B
AtriCure, Inc. (ATRC)United States$3.089B
HAEMONETICS CORP (HAE)United States$4.821B36.52
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87